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Abstract 
 
This paper evaluates the value of using a mobile 
digital technology for the purpose of collecting Patient-
Reported Outcome (PRO) data. We compare the use of 
a paper-based questionnaire and a mobile application 
as two different PRO instruments. Based on analysis, we 
conclude that use of the mobile application allows for a 
more nuanced picture of patients' health to be 
established. Implications for diagnosis and medical 
treatment are discussed along with the need for future 
research. 
 
 
1. Introduction  
 
A recent study by the OECD concluded that health 
spending has outpaced economic growth in member 
countries for the past 20 years, and that the rising 
healthcare costs are unsustainable without reform 
(http://www.oecd.org/health/healthcarecostsunsustaina
bleinadvancedeconomieswithoutreform.htm). 
Innovation of healthcare services is needed if the 
level of quality in healthcare is to be maintained [15]. 
This innovation is in part driven by emerging digital 
technologies, e.g. mobile technologies. Concurrently, 
public sector strategies like the one in Denmark call for 
patients playing a larger role in taking responsibility for 
their own health and medical treatment. Thus, the 
Danish Ministry of Health has defined 8 goals for the 
provision of national healthcare services [23] in 
collaboration with Local Government Denmark and 
Danish Regions. Increased patient involvement is 
among these goals. Meanwhile, patient-centered 
healthcare requires active engagement of patients [19]. 
In executing the strategy, use of digital technology is 
one of the means by which to increase involvement and 
patient empowerment. However, to ensure that the 
technology contributes to value creation, designers and 
developers of digital technology need to understand and 
consider the interests and needs of both patients and 
healthcare professionals. Our current knowledge is, 
however, limited and needs to be expanded through 
research. 
Technology has the potential to provide both 
healthcare professionals and patients with information 
in support of diagnosis and treatment. Doctors need 
accurate information to provide effective and cost-
efficient healthcare. Patients—especially with chronic 
diseases—need information in order to help themselves 
and self-manage their medical conditions. In many 
instances, both parties have incomplete information 
about patients' health and how their disease progresses 
[8]. In the case of patients with chronic diseases who 
need long-term healthcare, being able to continually 
monitor the patients and follow any developments is 
important from the perspective of doctors. Today, 
doctors rely to a large extent on test results (from 
periodic blood tests, scans etc.) and dialogue with 
patients. In connection with check-ups, patients are 
asked to account for not only their well-being and state 
of health right now, but also how they have been since 
their last check-up, e.g. whether they have experienced 
any pain and discomfort, and whether their disease has 
impacted their daily lives. The reliability of the data—
or information—provided by the patients is low due to 
their difficulties in recalling the details of everyday life 
with any accuracy [20]. 
The question is whether doctors can secure more 
reliable information about patients' health, and how data 
can be collected to that end by means of technology both 
automatically and manually. Data can be collected 
automatically by for example tracking patients' vital 
signs and physical movements through sensor 
technology. In addition, patients can be encouraged to 
manually report observations of a more subjective 
nature regarding their health by making it convenient, 
for example through mobile applications. This leads us 
to our research question: To what extent can digital PRO 
instruments be used to establish a more accurate picture 
of patients' health? We address this question in the 
context of a research project that investigates the 
relationships between pain, sleep, and disease activity in 
an attempt to identify causes of reduced physical 
activities and pain among children and adolescents 
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diagnosed with arthritis. We focus in particular on the 
value from the perspective of doctors of using a mobile 
application for collecting Patient-Reported Outcome 
(PRO) data. To that end, we compare it to a currently 
used PRO instrument—a paper-based questionnaire. In 
other words, we evaluate the efficacy of a digital PRO 
instrument as compared to conventional, paper-based 
methods of patient data collection. Based on our 
analysis, we conclude that the app provides more 
nuanced if not more accurate information, which opens 
for new healthcare possibilities and challenges. 
The paper is structured as follows. First, we account 
for state-of-the-art knowledge of digital healthcare with 
a specific focus on mHealth and technology support for 
PRO data collection. Second, we describe our research 
approach, including the use of an app that has been 
developed and tested as part of this study. Third, we 
present our findings, comparing questionnaire and app 
data through statistical analyses. Fourth, we discuss the 
results in relation to extant literature, stressing the 
contribution to mHealth research and the value of app 
technology for PRO data collection. 
 
2. Background literature  
 
In this section, we account for extant research within 
mHealth, focusing in particular on digital technologies 
as instruments for collecting and analyzing PRO data. 
According to the World Health Organization there is 
no single, agreed-upon definition of mHealth. In their 
global survey of eHealth, mHealth (mHealth is a 
component of eHealth) is defined as "medical and public 
health practice supported by mobile devices, such as 
mobile phones, patient monitoring devices, personal 
digital assistants (PDAs), and other wireless devices" 
[28:6]. This is mirrored in the academic literature where 
mHealth is broadly defined as health service delivery 
over a mobile or wireless platform: "mHealth is all 
about delivering health services and information over a 
mobile platform" [17:671]. mHealth is closely related to 
digital health. Digital health is the use of digital 
technologies for the purpose of facilitating patients’ 
participation in the healthcare delivery process "to 
monitor and improve the wellbeing and health of 
patients and to empower patients in the management of 
their health and that of their families" [9:246]. 
Mobile, digital technologies like smartphones drive 
development of innovative healthcare solutions due to 
their unique characteristics, e.g. mobility, accessibility, 
and the ability to collect and transmit data [11]. The 
potential for mHealth applications is enormous and 
includes continuous surveillance of vital signs and 
physiological well-being, as well as access to virtual 
care services, drug information, personal electronic 
medical records, and a wealth of educational resources 
[14]. This is attracting the interest of practitioners and 
researchers alike, which is reflected in an increasing use 
of apps within the healthcare sector [4]. 
Among healthcare apps are those that are being used 
for collecting data from patients also known as Patient-
Reported Outcome (PRO) data. According to the U.S. 
Food and Drug Administration (FDA), "a patient 
reported outcome (PRO) is a direct response from the 
patient regarding his/her health condition, without a 
healthcare provider or caregiver interpretation" 
(https://www.fda.gov/ForPatients/PatientEngagement/d
efault.htm#_PRO__), and PRO instruments like apps 
are important tools in directly measuring how the patient 
feels and functions. These apps and mHealth in general 
are interesting in a health economics perspective, 
because "a small number of patients, mostly the 
chronically sick, are disproportionately costly in any 
health-care system. M-health offers a continuous, long-
term means of monitoring them, with the potential to 
improve the way conditions such as cardiovascular 
disease, epilepsy, asthma and diabetes are managed" 
[24]. Chronic non-communicable diseases account for a 
greater part of "the global disease burden" than that of 
"communicable diseases, maternal and perinatal 
conditions, nutritional causes and injuries put together 
and are expected to increase by 2020" [19:948]. Thus, 
mHealth has the potential to improve not only the 
interaction and dialogue between healthcare 
professional and patients but also the cost and quality of 
treatment [7]. 
Doctor-patient consultations can be conducted more 
efficiently if less time is spent on administration (e.g., 
accessing and inputting data in various health 
information systems) and more time in actual physical 
meetings between patients and doctors [26]. 
Paradoxically, doctors fear that new technology will 
increase rather than decrease their administrative 
burdens, and that their introduction will necessitate 
time-consuming training and work practice adaptations 
[21, 26]. Nevertheless, mHealth introduces a paradigm 
shift in the sense that mobile technologies stimulate 
innovation and reconceptualization of medical care. 
Work processes and routines are being rethought from 
the perspective of how best to accomplish the main 
objective of providing unsurpassed medical treatment 
regardless of how it has been accomplished in the past. 
The envisioned application areas are numerous. Apps 
could, for example, be used for data collection, patient 
monitoring, clinical decision-making, and information 
management [25]. 
According to Gallagher et al. (2015), patient-
centeredness is key to effective treatment of chronic 
diseases, which entails involving patients more directly 
in the treatment process. Regularly registering patient 
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data improves the quality of diagnoses and treatment, 
partly because healthcare professionals are able to adapt 
plans based on PRO data [6]. PRO data opens up new 
possibilities, and studies have shown the value of 
utilizing such data with regard to making early 
diagnoses and freeing up resources [10]. Turning 
patients into active participants increases treatment 
quality from a patient satisfaction perspective [21]. 
Furthermore, greater involvement contributes positively 
to patient compliance, which can be defined as "the 
extent to which a person's behavior—taking medication, 
following a diet, and/or executing lifestyle changes, 
corresponds with agreed recommendations from a 
health care provider" [27:136]. 
Despite its potential, there are also valid concerns 
regarding patient involvement. Among other things, the 
quality of PRO data is limited by patients' abilities (or 
lack thereof) to remember details about their conditions, 
which is referred to as recall bias: “A potential for recall 
bias exists whenever historical self-report information is 
elicited from respondents” [20:167]. In addition, studies 
show that motivating patients to use health apps is 
challenging despite the potential of improving their 
daily lives. Another challenge is establishing the clinical 
value of such PRO instruments, i.e. determining 
whether they improve not only doctors' work practices 
but more importantly patients' health. Consequently, 
more research on the value and limitations of digital 
technology enabled PRO instruments is needed [11]. 
LoPresti et al. (2015) have examined state-of-the-art 
research and clinical trials involving mHealth 
applications worldwide—most of which take place in 
the setting of chronic diseases—and conclude that 
"evidence in support of this technology is unclear from 
the trials included in this study … Further research 
should focus on establishing the effectiveness of 
particular mHealth applications and comparing the 
effectiveness of these new approaches with that of 
existing methods" [13:17, 24]. Our research contributes 
to filling that knowledge gap by investigating the extent 
to which digital technology can be used to establish a 
more accurate picture of patients' health. 
 
3. Research design  
 
In this section, we describe the research background, 
the case setting, and the instruments that were used for 
PRO data collection as part of the study. The following 
subsections will provide detailed descriptions of the app 
that was developed as part of the research project as well 
as our approach to data collection and analysis. 
This paper reports on the research collaboration 
between Department of Pediatrics and Adolescent 
Medicine at Aarhus University Hospital, Business 
Academy Aarhus, and Aarhus University. In 2016, a 
group of doctors at the Department of Pediatrics and 
Adolescent Medicine initiated a project entitled "Pain, 
sleep and disturbed circadian rhythm in Juvenile 
Idiopathic Arthritis" for the purpose of identifying 
pathological mechanisms behind reduced physical 
activity and children's pain. The doctors enlisted the 
help of Business Academy Aarhus to develop the How-
R-you app (see below) to empower patients to keep 
track of their daily symptoms and share the information 
with the doctors. The app is envisioned as a supplement 
to and potentially a substitute for more traditional means 
of collecting data about patients' health. 
The Department of Pediatrics and Adolescent 
Medicine at Aarhus University Hospital is responsible 
for both surgical and medical healthcare services to 
children and adolescents in the ages from 0 to 18 years, 
including pediatric rheumatology. Diagnosing and 
treating children and adolescents with arthritis is a 
multidisciplinary teamwork involving doctors, nurses, 
psychologists, and physiotherapists—all trained and 
experienced in pediatric rheumatology. The main goal 
is to detect and aggressively treat arthritis in order to 
preserve normal joint function and growth. 
Despite new medical treatment modalities, this 
group of patients experience reduced quality of life with 
pain, decreased physical activity, and sleep disturbances 
as major contributors to morbidity [12, 18]. Patients 
receive routine check-ups in an outpatient clinic 
between 2 and 6 times a year depending on individual 
needs. In case of acute arthritis flare, an extra check-up 
is scheduled and the patient is closely monitored until 
the disease is under control. Such flares can be detected 
in patients as painful or swollen joints, but in some cases 
the symptoms are not manifest. However, a decrease in 
physical activity and general well-being can be 
indicative of an arthritis flare. Flares are evaluated by 
physical examination of all joints, eyes, skin, and 
mucosa. Biochemistry and imaging can assist the 
identification of disease activity. Early detection of a 
flare as well as monitoring disease related symptoms 
such as chronic pain, sleep disturbances, and decreased 
physical activity is important in the care of arthritis 
patients. Doctors rely on PRO data in diagnosing and 
monitoring the disease. It can, however, be difficult for 
children and adolescents to recall specific symptoms 
and accurately report changes in their state of health 
over time. 
With regard to information about patients' health, the 
doctors depend in part on an internationally recognized 
questionnaire—Juvenile Arthritis Multidimensional 
Assessment Report (JAMAR) [3]. JAMAR is a 
parent/patient-reported outcome measure that is used in 
assessing patients' physical and mental well-being, 
including how pain is experienced and influences their 
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mood and behavior. It also contains disease and 
medication specific questions related to arthritis 
treatment. The questionnaire is intended to be 
completed prior to a scheduled meeting with the doctor. 
The answers rely on recalled experiences of disease 
symptoms during either the last week or last month. 
The app was introduced to counter recall bias and to 
give the children and their parents a tool for continually 
monitoring their overall state of health in contrast to 
only assessing it at fixed points in time, i.e. before a 
check-up. The app serves as a means of developing a 
multidimensional understanding of pain and the effects 
of pain on everyday life for children with arthritis. To 
that end, we designed the questions on the basis of 
recommendations from the International Association for 
the Study of Pain, and included the following "core 
outcome domains and measures that should be 
considered in clinical trials of treatments for acute and 
chronic pain in children and adolescents" [16:771]: pain 
intensity, physical functioning, emotional functioning, 
and role functioning. In order to automatically monitor 
physical activity and sleep (physical functioning) we 
included the GENEActiv device (see below). 
 
3.1. The How-R-you app 
 
The idea behind the How-R-you app came from the 
doctors who were concerned about the low quality of 
PRO data when paper-based questionnaires are used for 
data collection purposes. The reliability and validity of 
such data are questionable because patients report on 
their health and well-being at fixed points in time rather 
than on a continuous basis, and they furthermore have 
to rely on their ability to recall past behaviors and health 
conditions. The app is envisioned as a substitute for the 
paper-based questionnaires and as a solution to the data 
quality problems. 
The app is available through the Apple App Store 
and Google Play. It can also be downloaded here: 
http://how-r-you.online/en/ 
The app has been developed in an iterative process 
involving patients, doctors, UX designers, and 
programmers. Through requirements elicitation, it 
became evident that patients want an easy-to-use tool 
that allows for daily health registrations and which 
provides an overview of their health history. 
Additionally, they asked for a free-form text field that 
allows them to write daily notes in a diary-style form to 
help them monitor their chronic disease. 
How-R-you allows for convenient data collection 
from patients by means of, e.g., smartphones and tablets. 
The app contains modularized and configurable health 
related questions. It also includes a diary and provides 
an overview of historical data through graphs (see 
Figure 2) and tables. The app also integrates with the 
GENEActiv accelerometer and collects sensor data. 
GENEActiv is a wrist-worn actigraphy device that is 
used for temperature, light, and activity monitoring. The 
sensor data can be analyzed in order to show the 
patient's level of physical activity and sleep pattern. 
(https://www.activinsights.com/products/geneactiv/). 
All registered data is sent in real time to a central 
database from which doctors and patients can access the 
data as needed. The data is password protected and 
encrypted to ensure that only authorized personnel have 
access to the data. 
The app is designed with user-friendliness in mind. 
As a substitute for paper-based questionnaires, it is an 
interactive tool that requires only a few activity steps on 
the part of users. Both the home screen of the app and 
the modularized questions are configurable to serve the 
individual needs of doctors and patients. Due to the 
feedback from patients and doctors during the design 
process, the number of questions, their wording, and 
response formats (e.g., numerical input, multiple choice, 
and slider scales) are tailorable to individual needs. 
In this study, the app is configured to include two 
modules, "Pain" and "Pain relief", which are accessible 
through the dashboard on the home screen depending on 
user settings (see Figure 1). 
 
 
 
Figure 1. How-R-you home screen 
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In addition, it provides an overview of the patient's 
activity as monitored through the GENEActiv 
actigraphy device (see Figure 2). 
 
 
Figure 2. GENEActiv activity graph 
 
The "Pain" module (see Figure 3) contains questions 
about pain intensity, where it is located, as well as the 
patient's level of physical activity, mood, and ability to 
participate in everyday activities. "Pain relief" focuses 
on methods and effects of relieving the pain, e.g. what 
the patient has done to alleviate the pain and what the 
outcome has been. The response format is an 0-10 slider 
scale (also known as Visual Analog Scale). The "Pain" 
questions are documented in the appendix. 
 
 
Figure 3. How-R-you "Pain" module 
 
3.2. Data collection 
 
As mentioned in the introduction, this paper is based 
on a research project that investigates the relationships 
between pain, sleep, and disease activity in an attempt 
to identify causes of reduced physical activities and pain 
among children and adolescents diagnosed with 
arthritis. The long-term goal is to identify effective 
methods of treatment and pain relief and as a 
consequence improve the quality of life among patients. 
98 patients are included in the study "Pain, sleep and 
disturbed circadian rhythm in Juvenile Idiopathic 
Arthritis". It was determined that 85 would be sufficient 
to cover patients aged 6-16 years diagnosed with all 7 
types of arthritis. The study has been approved by the 
regional committee on health research ethics and 
complies with applicable data protection laws. Informed 
consent was obtained from all participants and their 
guardians. The patients received instructions by a 
medical student and researcher. 
Each patient participates over a three-month period, 
it includes two outpatient check-ups—one at inclusion 
and one by the end of the study—the purpose of which 
is routine assessments of disease activity. The patients 
were required to wear the GENEActiv device for the 
purpose of monitoring their level of physical activity 
and sleep pattern. They were also asked to write sleep 
diaries, fill out JAMAR questionnaires, and use the 
How-R-you app for one week following each of the two 
check-ups.  
JAMAR is a paper-based questionnaire. In this 
study, the validated Danish translation of JAMAR was 
imported into REDCap, which is "a web application for 
building and managing online surveys and databases" 
(https://www.project-redcap.org). It was subsequently 
e-mailed to the parents of children included in the study. 
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They were asked to fill out the JAMAR questionnaire 
on the day of the check-up. Furthermore, the patients 
were asked to download How-R-you, were provided 
with unique login information, and were asked to use the 
app daily. They were instructed to answer the app 
questions at least once a day for a week while wearing 
the GENEActiv device. All patients participated twice 
during the study—one week at the beginning of the 
research project and one week toward the end. The 
GENEActiv device served to identify each patient's 
circadian rhythm and ascertain whether this rhythm was 
affected by the patient's experienced pain. In evaluating 
and choosing between many different actigraphy 
devices, we opted for many sensory registrations per 
minute over a one-week period rather than fewer 
registrations over a longer period of time. Data from 
both weeks are included in the dataset. Each patient was 
assigned a unique ID in REDCap and stored along with 
How-R-you credentials. 
All app activities and patient registrations (both in 
JAMAR and How-R-you) were recorded and 
timestamped. All data have been exported from the 
database for the purpose of data analysis using the Stata 
statistics software package (https://www.stata.com). 
 
3.2.1. Ethics. In relation to our data collection, we 
discussed at length the potential risk and ethical concern 
of sickening the patients. By asking patients to daily 
monitor their health and respond to questions in the app, 
there is a possibility of constantly reminding the patients 
that they suffer from a chronic disease beyond the 
disease's normal cognitive saliency, which might 
influence their mood and mental well-being—and thus 
their state of health—in a negative way. For most 
patients the disease is, however, already a conscious part 
of their everyday lives. Furthermore, there is no well-
established pain assessment method. Previous studies 
have confronted patients with variable number of 
questions about when patients experience pain [2]. For 
the purpose of this study we decided to monitor patients' 
health continuously and ask them to answer questions at 
least once a day. We therefore assess the risk as very 
low to the point where it is a concern that needs to be 
monitored as our ongoing research efforts move 
forward. 
 
3.3. Data analysis 
 
The analyses are based on cross sectional time-series 
data (panel data) since the data has been collected over 
two different time periods through, on the one hand, the 
JAMAR questionnaire and, on the other hand, the How-
R-you app (December 2016 – November 2017). 
Because of the nature of the data (cross sectional 
time-series data), the analyses are based on panel data 
models describing individual behavior over time and 
across individuals. There are several estimation 
techniques for analyzing panel data models, but at a 
general level there is a distinction between pooled 
Ordinary Least Squares (OLS) models, fixed effects 
models, and random effects models. We rely on both 
fixed and random effects models depending on the 
particular regression model, since Hausman 
specification tests have shown them to be the most 
appropriate and effective estimation techniques (for 
more about fixed and random effects, see [5]). 
A Hausman specification test has been conducted for 
each regression model to determine if the specific 
regression model should be estimated using either fixed 
or random effects. Fixed effects are used if the p-value 
of the Hausman test falls below 0.05 (significance 
level), and random effects are used if the p-value 
exceeds 0.05 [1]. All analyses are based on the 
recognized 0.05 significance level (p <0.05), but since 
the number of respondents are relatively low, relations 
at an 0.1 significance level (p <0.1) are highlighted as 
well. When p < 0,001, it is also emphasized. Each 
regression model displays the bivariate relationship 
between the study’s independent (pain intensity) and 
dependent variables (level of physical activity, mood, 
and participation in activities) and is analyzed using 
Stata. 
In the appendix, we have listed the questions that are 
compared across JAMAR and How-R-you. Despite 
differences in wording, the same questions (variables) 
are included in both the questionnaire and the app. 
 
4. Analysis  
 
In this section, we compare questionnaire (JAMAR) 
and app (How-R-you) responses through descriptive 
statistics and regression analysis. In the end, we 
conclude that the app as a PRO instrument provides for 
a more nuanced picture of patients' health. 
If we compare JAMAR and How-R-you responses, 
we see some interesting results. In terms of descriptive 
statistics, 61% of all respondents have answered both 
JAMAR and How-R-you questions. 93 respondents 
have filled out the questionnaire and 66 have used the 
app. 
The average registered pain intensity is higher when 
looking across questionnaire responses compared to the 
app data. However, the maximum registered pain is 
higher in the app than in the questionnaire. This is 
consistent with extant research, which shows that 
patients respond to questions regarding pain based on 
the maximum pain intensity experienced. 
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Table 1 displays a comparison of patients' responses 
to questions regarding average pain intensity, level of 
physical activity, mood, and participation in activities in 
both the JAMAR questionnaire and the How-R-you app. 
 
Table 1. Comparison of questionnaire and app 
responses 
 Model I 
Pain 
intensity 
Model II 
Physical activity 
Model 
III 
Mood 
Model 
IIII 
Activity 
App -0,588 
(0,422) 
0,576* (0,271) -0,633 
(0,386) 
-1,582** 
(0,461) 
Constant 3,150** 
(0,672) 
-,060(0,432) 2,273** 
(0,613) 
4,333** 
(0,732) 
n 129 127 128 128 
R2 0,015 0,035 0,021 0,086 
*p < 0,05; **p < 0,001. Reference category for the app is the 
questionnaire. The dependent variables are scaled from 0-10, where 
10 indicates a high impact of pain on level of physical activity, mood, 
and participation in activities, and conversely 0 indicates a low impact. 
 
The respondents indicate that the experienced pain 
has influenced their level of physical activity (in terms 
of, e.g., running, jumping, writing, and cutting with 
scissors)—less so when asked in the questionnaire (0,52 
on average) than in the app (1,09 on average). In other 
words, when asked daily about their health and well-
being, the patients indicate being more impeded by pain 
than when asked to look back at the period since their 
last consultation. This might be a sign of a coping 
mechanism or simply that patients do not remember the 
pain influencing their level of activity. 
When it comes to the experienced pain affecting 
their mood, the app score (1,01 on average) is lower than 
that of the questionnaire (1,64 on average). Meanwhile, 
the maximum registered value in the app (10) is 
identical to that of the questionnaire (10). 
Similarly, looking at the extent to which the 
experienced pain has prevented the patients from 
participating in their usual activities (e.g., going to 
school, playing with friends, and participating in sports), 
the app score (1,17 on average) is lower than that of the 
questionnaire (2,75 on average). As with the impact of 
pain on their mood, the maximum registered value in the 
app (10) is identical to that of the questionnaire (10). 
The regression analyses show that there is no 
significant difference between the registered pain 
intensity and mood across app and questionnaire. 
Looking at the beta coefficients, it can be inferred that 
the pain intensity and mood fall by 0.59 (-0,59) and 0,63 
(-0,63) points respectively (NB: The dependent variable 
is scaled from 0 to 10) when transitioning from filling 
out the questionnaire to using the app. Opposite results 
are seen with regard to the level of physical activity and 
participation in activities in the sense that there are 
significant differences across app and questionnaire. 
The beta coefficients show that the level of physical 
activity increases by 0.58 points and participation in 
activities falls by 1,58 (-1,58) points respectively when 
going from the questionnaire to the app. The results with 
regard to pain intensity, mood, and participation in 
activities are consistent with expectations of lower 
values registered in the app compared to the 
questionnaire. 
Table 2 displays how the patients' pain intensity 
affects their level of physical activity, mood, and 
participation in activities. 
 
Table 2. Effect of pain intensity on level of 
physical activity, mood, and participation in 
activities 
 Model I 
Physical 
activity (RE) 
Model II 
Mood (RE) 
Model III 
Activity 
(RE) 
Pain intensity 0,303** 
(0,054) 
0,435** 
(0,074) 
0,631** 
(0,088) 
Constant 0,130 (0,187) 0,328 
(0,248) 
0,503† 
(0,297) 
n 127 128 128 
Rho 0,357 0,136 0,196 
†p < 0,1; **p < 0,001. Reference category for the app is the 
questionnaire. The dependent variables are scaled from 0-10, where 
10 indicates a high impact of pain on level of physical activity, mood, 
and participation in activities, and conversely 0 indicates a low impact. 
 
The regression analyses show significant 
relationships between pain intensity, on the one side, 
and physical activity, mood, and participation in 
activities on the other side. The beta coefficient 
indicates that the impact of pain on level of physical 
activity rises 0,30 when the pain increases 1 point in 
intensity. For mood and participation in activities, the 
effects are 0,43 and 0,63, respectively. 
 
5. Discussion  
 
This paper is the first step in addressing the need for 
more research that investigates the clinical value of PRO 
instruments (Lee et al. 2015) for the purpose of 
improving accuracy in patient data collection. In this 
paper, we look at the value from the perspective of 
doctors in evaluating whether the How-R-you app 
provides them with more valid and reliable information 
about patients' health compared to the periodic survey 
instrument JAMAR. Such information has the potential 
to improve medical work practices in support of 
diagnosis and treatment by enabling the doctors to make 
more informed and timely decisions based on more 
nuanced if not more accurate pictures of patients' health. 
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The analyses show that even patients who are 
severely tormented by pain experience days with little 
or no pain. The app data allows for more detailed 
information about patients' health in the sense that the 
actual frequency of days with pain can be visualized 
together with the impact of pain on everyday life. As a 
consequence, doctors and patients have the means to 
recognize symptom patterns, indicating disease flare or 
the need to adjust pain treatment. Proper detection of a 
flare by comparing the associated pain with chronic pain 
is crucial for selecting the correct treatment. Early 
detection of a flare will signal a need for more intensive 
arthritis treatment. If the pain is chronic in nature, it is 
helpful to reflect on "good" as well as "bad" days, i.e. 
days with less versus more pain, because it may inform 
an effective treatment strategy. Daily app registrations 
of pain and how it affects patients in their daily lives 
provide doctors with a more nuanced picture of patients' 
health. In the future, this nuanced picture can be used to 
improve treatment and thereby the health of this patient 
group. 
The well-known relationship between high pain 
intensity, low mood, decreased physical activity, and 
diminished social functioning [22] is captured by both 
JAMAR and How-R-you. However, some differences in 
patients' responses to questionnaire and app questions 
are significant, namely with regard to the level of 
physical activity and participation in activities, whereas 
others are not, specifically pain intensity and mood. This 
supports our assumption that patients answer JAMAR 
questions based on the most intensive pain they recall 
having experienced during the previous period. 
However, because the patients have used the app 
differently (some have used it several times a day and 
others have not used it every day despite the doctors' 
instructions), it is not possible to make any conclusions 
about pain variation over time across patients. 
Meanwhile, looking at individual patients' responses, 
for example with regard to pain intensity, substantial 
differences are clearly discernable, which again 
confirms our expectation that using the app supports a 
more nuanced picture of patients' health. This more 
nuanced picture of patients' health makes it possible to 
better evaluate whether certain pain management 
interventions (e.g., music therapy and meditation) have 
the desired effects. Moreover, with regard to the choice 
of treatment strategies (for example during "patient-
centered talks"), the app data can be used because they 
allow for a discussion of day-to-day activities, and how 
they relate to experienced pain, medication, and much 
more. 
Though we expected that the app facilitates a more 
accurate picture of patients' health, because they are 
asked to register data daily regarding their current health 
conditions compared to more retrospective evaluations 
over a longer period of time when they respond to the 
questionnaire, our analyses are inconclusive due to the 
fact that some of the identified differences are 
significant while others are not. However, there are clear 
advantages of using the app for collecting PRO data, not 
least the ability to establish a link between pain 
experienced now or very recently, patients' daily 
activities, and their well-being. In JAMAR, the patients 
answer many questions regarding their physical 
conditions that are not necessarily relevant to every 
child or adolescent. Moreover, because the answers 
relate to past experiences—sometimes weeks in the 
past—it is much more difficult to assess the impact of 
pain. 
Although some differences across How-R-you and 
JAMAR are not significant, it is important to note the 
relatively small sample size, which may account for the 
non-significant differences in questionnaire and app 
responses. Looking at the individual responses, there are 
substantial differences in each patient's answers across 
JAMAR and How-R-you which confirms our 
expectation that the app facilitates a more nuanced—if 
not more accurate—picture of patients' health, and how 
pain influences their daily lives. 
In summary, our study shows that digital PRO 
instruments like How-R-you can provide doctors with 
valid and reliable information in support of planning, 
monitoring, and improving treatment. In addition, such 
instruments may potentially increase patient satisfaction 
and compliance through their active involvement. 
Moreover, the PRO data may improve patient-doctor 
communication for the purpose of ensuring effective 
treatment strategies. However, since this study adopts 
the perspective of doctors, future studies are needed to 
investigate these potential values. 
 
5.1 Limitations 
 
In this study, we have investigated the potential 
value of using an app for collecting PRO data from the 
perspective of doctors. The data collected through the 
app helps doctors better diagnose diseases and monitor 
patients' health. In the end, because data is not collected 
automatically but needs to be registered manually by 
patients, it is important that patients are motivated, and 
that the app facilitates easy data registration. We are 
currently investigating the value perspective of patients. 
One of the envisioned benefits of using How-R-you is 
that patients have the possibility of monitoring their own 
medical conditions and reflecting on questions 
regarding their health (How much pain am I 
experiencing right now? How does it impact my 
physical condition and mental well-being?) in the hope 
that it may lead to pattern recognition (When did I 
experience it the last time? How did I cope? What was 
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the effect?) and an improved ability to self-manage their 
disease on a daily basis. An important limitation of our 
study is that we do not control for the use of different 
technologies for data collection purposes. It is possible 
that the use of digital technologies (e.g., How-R-you) 
might influence not only data reporting but also the 
reported data and therefore the subsequent analysis. 
Future studies should consider including control 
variables such as computer self-efficacy, level of 
experience with digital technology, overall technology 
affinity etc. 
Meanwhile, anecdotal evidence indicates that 
patients primarily use the app, because they want to help 
the doctors. Consequently, we need to better understand 
what motivates patients, and how they can be 
encouraged to take greater part in managing their own 
health, for example through technology use. To that end, 
we are studying the information needs of patients, and 
how digital technology like the app contributes to value 
creation from their perspective in order better to 
understand how to design and use such technologies. 
Our findings will be reported in forthcoming 
publications. 
 
6. Conclusion  
 
This paper reports on a study in which we set out to 
investigate the extent to which digital technology can be 
used to establish a more accurate picture of patients' 
health. We have collected PRO data using both a 
questionnaire and an app in a project that focuses on 
studying the relationships between pain, sleep, and 
disease activity among children and adolescents 
diagnosed with arthritis. We conclude that the use of 
digital technology (i.e., the app) allows for a more 
nuanced picture of patients' health to be established, and 
we discuss how the more detailed information can be 
used by doctors to better care for the patients through 
more effective treatment strategies and evaluation. In 
addition, we speculate that patients are better equipped 
to self-manage their disease. These advantages of using 
mobile digital technology have the potential to improve 
the health and quality of life of the patients. We will 
leave it to future studies to investigate this further. 
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Appendix 
 
Table A1 and A2 contain the questions for PRO 
data collection across JAMAR and How-R-you. 
 
Table A1. JAMAR questions 
1 "How much pain have you had because of the illness over the 
past week?" (VAS 0-10; score of 0 = "No pain" and score of 10 
= "Extreme pain") 
2 Evaluation of functional ability based on a JAFS (Juvenile 
Arthritis Functionality Scale) score; a 15-item questionnaire 
evaluating the child’s ability to perform specific tasks during the 
past four weeks (each item is scored 0-2 where 0 = "With NO 
difficulty", 1 = "With SOME difficulty", and 2 = "With MUCH 
difficulty"; total score range is 0-30) 
3 "Consider the past four weeks, have you had any difficulty 
carrying out activities that require a lot of energy?" (4-point 
Likert-type scale; 0 = "Never" and 3 = "Every day") 
4 "Consider the past four weeks, have you felt sad or depressed?" 
(4-point Likert-type scale; 0 = "Never" and 3 = "Every day") 
Table A2. How-R- you ("Pain") questions 
1 "Time" (time of day that the registration concerns is 
automatically detected but can be changed manually by the 
patient) 
2 "How much pain did you experience today?" (Visual Analog 
Scale (VAS) 0-10; score of 0 = "No pain" and score of 10 = 
"Extreme pain") 
3 "Where does it hurt today?" (multiple choices: head, neck, back, 
legs, feet, arms, hands, and no pain) 
4 "Does the pain mean you could not be as physically active as 
you would otherwise? (E.g., run, jump, write, cut with scissors)" 
(VAS 0-10; 0 = "Not at all" and 10 = "Completely prevented all 
activity") 
5 "Has the pain prevented you from doing what you would 
otherwise do today? (E.g., school, play with comrades, go to 
sports)" (VAS 0-10; 0 = "Not at all" and 10 = "Completely 
prevented all activity") 
6 "How much has the pain impacted your mood during the day?" 
(VAS 0-10; 0 = "No impact" and 10 = "Extreme impact") 
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